KP Tissue Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KPTSF research report →
Price Chart
About the company
Based in Mississauga, Canada, and incorporated in 2012, KP Tissue Inc. plays a significant role in the disposable tissue market. Through its ownership interest in Kruger Products L.
- CEO
- Dino J. Bianco
- IPO
- 2015
- Employees
- 2,800
- HQ
- Mississauga, ON, CA
Get TickerSpark's AI analysis on KPTSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $92.93M
- P/E
- 14.28
- PEG
- 0.07
- P/S
- 0.00
- P/B
- 1.79
- EV/EBITDA
- 0.74
- Div Yield
- 5.90%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 12.81%
- ROIC
- 0.00%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $0
- Net Income
- $8.50M+249.5%
- EPS
- $0.85+254.2%
- OCF Growth
- -100.0%
- FCF Growth
- -100.0%
- 52W High
- $9.60
- 52W Low
- $6.58
- 50D MA
- $9.26
- 200D MA
- $8.22
- Beta
- 0.44
- RSI (14)
- 58
- Avg Volume
- 144
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Kruger Products delivered a strong Q2 2026, with adjusted EBITDA up 25% year over year on higher U.S. volume, lower pulp costs, and better Memphis performance, while management still sees a soft Canadian market and is working on share recovery.· August 13, 2026
- Adjusted EBITDA rose 25% year over year to $90.6 million on revenue of $550.9 million.
- Revenue increased 2.8% year over year; U.S. revenue grew 9.5% while Canada declined 2.6%.
- Consumer adjusted EBITDA improved to $85.3 million with an 18.6% margin; AFH adjusted EBITDA was $8.5 million.
- Management expects Q3 2026 adjusted EBITDA to be in the range of Q2 results.
- The company sees Canadian market softness and private-label trading down, but says its share recovery plan is already showing early benefits.
Q2 2026 revenue was $550.9 million, up 2.8% year over year, and adjusted EBITDA was $90.6 million, up 25% year over year. Net income was $22.1 million, comparable to Q2 2025. Consumer revenue rose 1.9% to $457.6 million, while Away-From-Home revenue increased 7.4% to $93.3 million. Consumer adjusted EBITDA was $85.3 million with an 18.6% margin, and AFH adjusted EBITDA was $8.5 million with a 9.1% margin. Cash at quarter-end was $165.2 million versus $205.9 million at the end of Q1 2026, total debt was stable, leverage was 2.9x, and Q2 capex was $15.5 million. For 2026, capex is expected to be $90 million to $110 million. Management said Q3 2026 adjusted EBITDA is expected to be in the range of Q2 2026.
Dino Bianco said the company maintained strong momentum in Q2 despite an uncertain economic backdrop, helped by higher U.S. sales volume, lower pulp prices, and improving Memphis performance. He emphasized continued investment in brands, a second-half Canadian share recovery plan, and progress on the Western U.S. TAD facility. His tone was constructive but cautious, especially on Canadian consumer softness, tariffs, and the timing of the new U.S. mill project.
Michael Keays focused on the quarter’s financial improvement: adjusted EBITDA of $90.6 million on $550.9 million of sales, with margin expanding to 16.4% from 13.5% a year ago. He said the EBITDA increase was driven by Memphis mill performance, higher volume, and lower pulp prices, partly offset by freight and SG&A pressure. He also highlighted cash of $165.2 million, stable debt, 2.9x leverage, Q2 capex of $15.5 million, and full-year capex guidance of $90 million to $110 million including pre-engineering for the U.S. TAD extension.
Analysts focused on three themes: the Canadian share recovery plan, Memphis ramp benefits, and the timing and structure of the Western U.S. TAD project. Management said the share recovery will rely on price gap corrections, category management, added promotions, and better communication around product value, and that benefits were already starting to show in June. On Memphis, Dino said the site likely has another year before reaching maturity, with further upside from normalized maintenance and possible capacity additions. On TAD, he said the company is still doing due diligence on a greenfield site and wants more clarity on the macro backdrop before making a final decision, though he hopes to provide clarity before year-end.
The call showed improving profitability, with adjusted EBITDA up 25% and margin expanding to 16.4%, supported by U.S. growth, lower pulp costs, and Memphis execution. Management also sounded optimistic about continued recovery in Canadian share, AFH pricing actions, and longer-term U.S. expansion through the TAD project and Memphis capacity improvements.
Management acknowledged ongoing softness in the Canadian consumer market, with trading down to private label and some share losses in bathroom tissue and paper towels. The TAD project is taking longer than expected because of greenfield complexity and macro uncertainty, and Memphis still has about a year before reaching maturity. Freight, warehousing, SG&A, and potential tariff risk were also cited as pressures, even if management said the tariff exposure looks limited.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.3%
- Shares Outstanding
- 10.03M
- Float Shares
- 9.96M
Our KPTSF coverage
Recent articles, reports, and earnings notes.
No research on KPTSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KPTSF report →KP Tissue Q2 Earnings Call Highlights
marketbeat.com · Aug 14
KP Tissue Inc. (KPT:CA) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 13
KP Tissue Inc. Reports on Shareholders' Voting Results for the Election of Directors
newsfilecorp.com · Jun 15
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend KP Tissue Inc. Shareholders Vote "FOR" on all Resolutions at the Upcoming 2026 Annual Meeting of Shareholders
newsfilecorp.com · Jun 3
KP Tissue Announces Filing and Mailing of the Management Proxy Materials in Connection with Its 2026 Annual Meeting of Shareholders
newsfilecorp.com · May 21
KP Tissue Q1 Earnings Call Highlights
marketbeat.com · May 16
KP Tissue Inc. (KPT:CA) Q1 2026 Earnings Call Transcript
seekingalpha.com · May 14
KP Tissue Increases Quarterly Dividend to $0.21 per Common Share Due to the Change in Tax Designation
newsfilecorp.com · May 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.